Legal & General Group
ANRO icon

Legal & General Group’s Alto Neuroscience ANRO Stock Holding History

Legal & General Group’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.1K Buy
+2,543
New +$58.8K ﹤0.01% 2693
2025
Q2 		– Sell
-2,135
Closed -$4.61K – 3562
2025
Q1 		$4.61K Hold
2,135
– – ﹤0.01% 3287
2024
Q4 		$9.03K Hold
2,135
– – ﹤0.01% 3268
2024
Q3 		$24.4K Buy
2,135
+1,241
+139% +$15.2K ﹤0.01% 2970
2024
Q2 		$9.56K Buy
+894
New +$11.6K ﹤0.01% 3305

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Legal & General Group's ANRO Position: Q2 2026 in Review

Legal & General Group opened a new position in Alto Neuroscience (ANRO) in Q2 2026: 2,543 shares worth $67.1K. The stake represents ﹤0.01% of the portfolio and ranks #2693 among its holdings. This is a return to the name: Legal & General Group previously reported a position in ANRO as recently as Q1 2025.

Legal & General Group first reported a position in ANRO in Q2 2024 and has held it in 5 quarters since. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Legal & General Group held 2,543 shares of Alto Neuroscience worth $67.1K as of Q2 2026.
  • Alto Neuroscience was a new Legal & General Group position in Q2 2026.
  • Alto Neuroscience made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2693 holding.
  • Legal & General Group first reported a position in Alto Neuroscience in Q2 2024 and has held it in 5 quarters since.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.